John C. McKew
2020
In 2020, John C. McKew earned a total compensation of $1.2M as Chief Scientific and Chief Operating Officer at NewLink Genetics, a 119% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $276,044 |
|---|---|
| Option Awards | $365,475 |
| Salary | $436,300 |
| Stock Awards | $102,310 |
| Other | $35,641 |
| Total | $1,215,770 |
McKew received $436.3K in salary, accounting for 36% of the total pay in 2020.
McKew also received $276K in non-equity incentive plan, $365.5K in option awards, $102.3K in stock awards and $35.6K in other compensation.
Rankings
In 2020, John C. McKew's compensation ranked 7,781st out of 13,090 executives tracked by ExecPay. In other words, McKew earned more than 40.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,781 out of 13,090 | 41st |
Division Manufacturing | 3,281 out of 5,624 | 42nd |
Major group Chemicals And Allied Products | 1,330 out of 2,257 | 41st |
Industry group Drugs | 1,153 out of 1,957 | 41st |
Industry Pharmaceutical Preparations | 857 out of 1,462 | 41st |
Source: SEC filing on April 6, 2021.
McKew's colleagues
We found five more compensation records of executives who worked with John C. McKew at NewLink Genetics in 2020.
News
NewLink Genetics CEO Richard Hawkins' 2023 pay falls 25% to $953K
April 12, 2024
NewLink Genetics CEO Richard Hawkins' 2022 pay slips 6% to $1.3M
March 31, 2023
NewLink Genetics CSO John McKew's 2021 pay rises 15% to $1.4M
March 23, 2022
NewLink Genetics CEO Richard Hawkins' 2020 pay jumps 200% to $2.2M
April 6, 2021
NewLink Genetics Former Chief Executive & Scientific Officer Charles Link's 2019 pay falls 38% to $1.7M
June 23, 2020